| ²é¿´: 510 | »Ø¸´: 0 | ||
wxwxrͳæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú¸ßÊÖ:¾§ÌåÖÐδÅäλôÈËá»ùÍŵÄÓ«¹âÈçºÎ½âÎö(Ï£Íû¸½Éϲο¼ÎÄÏ×),лл
|
|
ÇóÖú¸ßÊÖ:¾§ÌåÖÐδÅäλôÈËá»ùÍŵÄÓ«¹âÈçºÎ½âÎö(Ï£Íû¸½Éϲο¼ÎÄÏ×),лл! ÓÃôÈËáÅäÌ峤ÁËÒ»¸ö¾§Ìå,Ö÷ÒªµÄÓ«¹â·åÓëÅäÌåÏà±ÈΪÀ¶ÒÆ(¿É·ñ½âÊÍΪligand-to-metal charge transfer (LMCT)). ¸üÖØÒªµÄÊÇ: »¹ÓÐÒ»¸öÈõµÄ·å¼¸ºõÓëÅäÌåµÄÓ«¹â·åÔÚͬһ¸öλÖÃ(ºìÒÆ8nm),¿É·ñ½âÊÍΪ¾§ÌåÖÐΪÅäλôÈËá·Ö×Ó[ligand-centered (LC) and ligand-to-ligand charge transfer(LLCT)] ÅäÌåÖк¬ÓÐËĸöôÈËá,ôÈËáµÄÅäλ·½Ê½ÎªÒ»¸öµ¥³ÝÅäλ,Á½¸öË«³ÝÅäλ,»¹ÓÐÒ»¸öôÈËáδÅäλ! ÅäÌåÓë½ðÊôÁ¬½ÓÐγɶþλnetwork½á¹¹,È»ºóͨ¹ýÇâ¼üÒÔABABAB¶Ñ»ýģʽÐγÉÈýά³¬·Ö×ӽṹ! Ó«¹â·½ÃæÐ¡µÜΪ²ËÄñ,ÅθßÊÖÖ¸½Ì(×îºÃ¸½Éϲο¼ÎÄÏ×,ÎÄÕÂÒªÒýÓÃ)!·Ç³£¸Ðл! |
» ²ÂÄãϲ»¶
̨ÖÝѧԺÓÐÐò¶à¿×²ÄÁÏÍŶÓ×îºó³å´Ì£¬Í¬Ñ§ÃDZð´í¹ýŶ£¬ÇëËÙÁªÏµ£¡
ÒѾÓÐ0È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧÎïÀí»¯Ñ§¿ÎÌâ×é½ÓÊÕµ÷¼ÁÉú£¬Ãû¶î»¹ÓУ¬ËÙÀ´
ÒѾÓÐ0È˻ظ´
ÎÞ»ú»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ89È˻ظ´
Çó̼ËáÄÆºÍ̼ËáÇâÄÆµÄ¾§°û½á¹¹Í¼»ò¾§Ìå½á¹¹Í¼
ÒѾÓÐ0È˻ظ´
Çó̼ËáÄÆºÍ̼ËáÇâÄÆµÄ¾§°û½á¹¹Í¼»ò¾§Ìå½á¹¹Í¼
ÒѾÓÐ0È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧÎïÀí»¯Ñ§¿ÎÌâ×é½ÓÊÕµ÷¼ÁÉú£¬12µã¿ªÆô£¬ËÙÀ´
ÒѾÓÐ0È˻ظ´
¡¾2026 ¿¼Ñе÷¼Á¡¿¹þ¶û±õ¹¤³Ì´óѧ ÕÐÊÕѧ˶µ÷¼ÁÉú£¨Ó¢ÓïÒ»¡¢Êýѧһ£©
ÒѾÓÐ0È˻ظ´
ËÄ´¨Çữ¹¤´óѧ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ ¸¶êŽÌÊÚ¿ÎÌâ×éÕÐÊÕµ÷¼Á˶ʿÑо¿Éú
ÒѾÓÐ11È˻ظ´
Ñγǹ¤Ñ§Ôº²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺ½»Í¨ÔËÊäרҵ˶ʿÑо¿Éúµ÷¼ÁÕÐÉú
ÒѾÓÐ0È˻ظ´













»Ø¸´´ËÂ¥